Alexander Claviez
Overview
Explore the profile of Alexander Claviez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
1511
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Daw S, Claviez A, Kurch L, Stoevesandt D, Attarbaschi A, Balwierz W, et al.
JAMA Oncol
. 2025 Jan;
PMID: 39745682
Importance: The current standard-of-care salvage therapy in relapsed/refractory classic Hodgkin lymphoma (cHL) includes consolidation high-dose chemotherapy (HDCT)/autologous stem cell transplant (aSCT). Objective: To investigate whether presalvage risk factors and fludeoxyglucose-18...
2.
Engertsberger L, Benesch M, Mynarek M, Tonn S, Obrecht-Sturm D, Perwein T, et al.
Neurooncol Adv
. 2024 Dec;
6(1):vdae179.
PMID: 39713042
Background: Ependymomas of the spinal cord are rare among children and adolescents, and the individual risk of disease progression is difficult to predict. This study aims to evaluate the prognostic...
3.
Toskov V, Cseh A, Claviez A, Drexler B, Rotari N, Schwarz-Furlan S, et al.
J Pediatr Hematol Oncol
. 2024 Apr;
46(5):e354-e359.
PMID: 38652069
We report 5 children with bone marrow failure (BMF) after primary varicella zoster virus (VZV) infection or VZV vaccination, highlighting the highly variable course. Two patients were treated with intravenous...
4.
Rensing-Ehl A, Lorenz M, Fuhrer M, Willenbacher W, Willenbacher E, Sopper S, et al.
J Allergy Clin Immunol
. 2023 Nov;
153(1):297-308.e12.
PMID: 37979702
Background: Elevated TCRαβCD4CD8 double-negative T cells (DNT) and serum biomarkers help identify FAS mutant patients with autoimmune lymphoproliferative syndrome (ALPS). However, in some patients with clinical features and biomarkers consistent...
5.
Elischer P, Caliebe A, Nagel I, Bergholz R, Schrappe M, Claviez A, et al.
Am J Med Genet A
. 2023 Oct;
194(2):400-401.
PMID: 37789234
No abstract available.
6.
Claviez A, Moritz J, Yuan M, Vieth S, Bergholz R, Ahmeti H, et al.
Klin Padiatr
. 2023 Mar;
235(3):185-187.
PMID: 36990436
No abstract available.
7.
Mauz-Korholz C, Landman-Parker J, Fernandez-Teijeiro A, Attarbaschi A, Balwierz W, Bartelt J, et al.
Lancet Oncol
. 2023 Mar;
24(3):252-261.
PMID: 36858722
Background: Children and adolescents with early-stage classical Hodgkin lymphoma have a 5-year event-free survival of 90% or more with vincristine, etoposide, prednisone, and doxorubicin (OEPA) plus radiotherapy, but late complications...
8.
Meinel J, Yumiceba V, Kunstner A, Schultz K, Kruse N, Kaiser F, et al.
J Med Genet
. 2022 Oct;
60(5):469-476.
PMID: 36227713
Background: Duplications at the Xp21.2 locus have previously been linked to 46,XY gonadal dysgenesis (GD), which is thought to result from gene dosage effects of (), but the exact disease...
9.
Eichinger A, Poetschger U, Glogova E, Bader P, Basu O, Beier R, et al.
Leukemia
. 2022 Sep;
36(11):2567-2576.
PMID: 36097283
Total body irradiation (TBI)-based conditioning is associated with superior leukemia-free survival in children with ALL undergoing HSCT. However, the risk for subsequent malignant neoplasms (SMN) remains a significant concern. We...
10.
Vogiatzi F, Heymann J, Muller K, Winterberg D, Drakul A, Rosner T, et al.
Blood Adv
. 2022 Jul;
6(16):4847-4858.
PMID: 35820018
Immunotherapy has evolved as a powerful tool for the treatment of B-cell malignancies, and patient outcomes have improved by combining therapeutic antibodies with conventional chemotherapy. Overexpression of antiapoptotic B-cell lymphoma...